Ayahuasca Helped Will Smith ‘Surrender’ and More Psychedelic Revelations From Actor’s Memoir ‘Will’
“If I’m this beautiful, I don’t need #1 movies to feel good about myself,” Will Smith writes in memoir detailing his first ayahuasca ceremony.
Author: Greg Gilman
Veteran Who Cured PTSD with MDMA-Assisted Therapy Wows NBC ‘Today’ Show Anchors
“This treatment is the reason that my son has a father instead of a folded flag,” a once-suicidal Iraq War veteran tells Savannah Guthrie.
TRIPP Wants You to ‘Be Here Now,’ With or Without Ram Dass
Psychedelic Spotlight trips with Ram Dass at the 50th anniversary celebration of the spiritual teacher’s iconic book.
Can the Psychedelics Boom Go Bust? A Conversation with Cybin Chief Clinical Officer Dr. Alex Belser
“Something that people used to speak about only in whispers is now standard policy,” says the psychedelics researcher, with 20 years of experience, in a wide-ranging Q&A.
Driver’s Licenses to Trip on Psychedelics by 2035? Rick Doblin Maps Out the Future of ‘Spiritualized Humanity’
The MAPS founder, who will speak at psychedelic conference Wonderland Miami next month, predicts clinics that administer the medicines will become licensing bodies for personal use.
Melissa Etheridge Comes Out for Psychedelics: ‘Psilocybin Is a Real Key’
“Let’s spend the time researching, looking into how these plant medicines were made to help us,” the two-time Grammy winner says during end-of-life psychedelic conference.
How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’
CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company’s lead candidate may be better than psilocybin.
Will Smith’s Son, Jaden, Is Also Into Psychedelics
But the 23-year-old actor and musician doesn’t specify which psychedelics he uses to explore “mystical states of consciousness.”
Will Smith Comes Out of the Psychedelic Closet
And it sounds like we’ll hear more about his psychedelic experiences on ayahuasca in his upcoming memoir, simply titled “Will.”
Why NeonMind Is Betting on Psilocybin to Curb the Global Obesity Epidemic
The psychedelic bioscience company’s top advisor tells Psychedelic Spotlight that psilocybin “affects at least the 5h2C receptor, which is dedicated towards appetite and appetite suppression.”
End of content
End of content